azathioprine has been researched along with sildenafil citrate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Andrade, J; Colby, T; Collard, HR; Gentry-Bumpass, T; Kaner, RJ; Lynch, D; Schwarz, M | 1 |
Banfield, L; Coyne, J; Cui, S; Guy, B; Helmeczi, W; Husnudinov, R; Jones, A; Khalid, MF; Kolb, MR; Mah, J; Pitre, T; Scallan, C; Su, J; Zeraatkar, D; Zhang, M | 1 |
1 review(s) available for azathioprine and sildenafil citrate
Article | Year |
---|---|
Medical treatments for idiopathic pulmonary fibrosis: a systematic review and network meta-analysis.
Topics: Acetylcysteine; Adult; Azathioprine; Humans; Idiopathic Pulmonary Fibrosis; Network Meta-Analysis; Sildenafil Citrate | 2022 |
1 trial(s) available for azathioprine and sildenafil citrate
Article | Year |
---|---|
The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet): diagnostic and adjudication processes.
Topics: Azathioprine; Biopsy; Diagnosis, Differential; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Idiopathic Pulmonary Fibrosis; Immunosuppressive Agents; Male; Phosphodiesterase 5 Inhibitors; Prednisone; Retrospective Studies; Sildenafil Citrate; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
1 other study(ies) available for azathioprine and sildenafil citrate
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |